E-mail: sales@hlsw-bio.com
 
   
  +86-0510-85629785
   
  sales@hlsw-bio.com
info@hlsw-bio.com
   
  No.138,Mashan Meiliang Road,Binhu, Wuxi,Jiangsu Province,China
 
   
  News Your location: Home -News
 
   
   
Bulk raw material export no longer

Views9707      originAdministrator      Add time2014-9-28
..........................................................................................................................................................................................................................................

Raw material medicine has been China's most unique pharmaceutical export varieties, absolute share of raw material medicine market in the world. Data shows, 2013, Chinese api exported 23598000000 US dollars, accounting for China's pharmaceutical health care products exported a total of 46.27%.
Data shows, in 2012 China's raw material exports amount to $22700000000, a year-on-year growth of 3.2%, accounted for 47.7% and pharmaceuticals exports total exports 82.5%; if the deduction of medical device products, raw material medicine exports accounted for 75.6%. of visible, raw material medicine still is our country medicines and health products of export commodities first category. But since the fourth quarter of 2012 compared to the same period, China's exports of bulk materials was consecutive quarter of negative growth, and the amplitude is widening, the third quarter of 2013, down 9.52% year-on-year, to record the largest decline. Although the fourth quarter decline in the pace of the bulk raw material exports slowed, but still unable to reverse the continuing downward export decline.
The characteristics of raw materials export growth significantly
Due to the recent years is in innovative drug research and development boom, the characteristics of raw materials has also become a major focus of industry chase. Industry sources, the characteristics of raw materials to profits in the patent expiration at the beginning can be as high as 50%, compared with the bulk raw material, profit rate is higher than 10 times. Chamber of Commerce vice president Xu Ming said, in 2013 the import and export China medicines and health products, compared with the bulk raw material, the characteristics of China's raw materials export growth momentum strong, strong growth characteristics of raw materials in the half of the top ten exports, and with the majority of cardiovascular medicine.
According to the international pharmaceutical market testing platform to provide the data, from 2013 the export volume of the top ten portion of the characteristics of raw materials export situation, export volume compared with the same period last year five increase five drop, but notable is, of which five kinds of characteristics of raw materials exports growth is much larger than the other characteristics of raw materials fell. Such as irbesartan, exports amounted to $112270000, an increase of 79.30%; exports of meropenem for $57000000, an increase of 140.76%; exports of spironolactone was $54740000, an increase of 22.74%. in the fall in exports the characteristics of raw materials, the largest decline is hydrochloric acid million trichomycin, exports to 74510000 US dollars, down the rest of the decline of more than 37.33%, within 10 percentage points.








Prev��Raw material medicine serious excess capacity

Next��Chinese material medicine industry come to the crossroads of transformation and upgrading
       
  Add:No.138,Mashan Meiliang Road,Binhu, Wuxi,Jiangsu Province,China
Tel:+86-0510-85629785   Fax:+86-0510-85625359   E-mail:sales@hlsw-bio.com info@hlsw-bio.com
Copyright (c) Wuxi Helen Biotechnology Co., Ltd. All rights reserved    备案号:苏ICP备16043161号